期刊文献+

烧伤患者创面病原菌分布及耐药性分析 被引量:1

Distribution and drug resistance of pathogens isolated from wound of burn patients
原文传递
导出
摘要 目的调查烧伤患者创面病原菌的分布及抗菌药物的耐药性,以便指导临床合理使用抗菌药物。方法对2010年5月-2012年5月烧伤患者创面培养分离的病原菌采用法国生物梅里埃公司ATB Expression半自动细菌鉴定仪,按照《全国临床检验操作规程》进行细菌鉴定,采用K-B法进行药敏试验,按照2010年版CLSI标准判断结果;所有数据用WHONET5.6软件进行统计分析。结果共分离烧伤创面病原菌310株,革兰阳性菌204株占65.8%,以表皮葡萄球菌、溶血葡萄球菌、屎肠球菌、金黄色葡萄球菌为主,分别占19.7%、13.2%、8.4%、8.1%,革兰阳性菌对万古霉素、利奈唑胺、替考拉宁均100.0%敏感;检出革兰阴性菌106株占34.2%,以鲍氏不动杆菌、铜绿假单胞菌、阴沟肠杆菌、肺炎克雷伯菌为主,分别占8.7%、7.1%、3.9%、3.5%,其中泛耐药鲍氏不动杆菌占81.5%,耐碳青霉烯类铜绿假单胞菌占9.1%,肠杆菌科细菌对碳青霉烯类抗菌药物100.0%敏感。结论应加强烧伤创面病原菌的监测,为临床合理使用抗菌药物和严格执行消毒隔离措施提供参考依据。 OBJECTIVE To investigate the distribution and drug resistance of pathogens isolated from wounds of burn patients so as to provide guidance for reasonable clinical use of antibiotics. METHODS From May 2010 to May 2012, the pathogens cultured from the wounds of the burn patients were identified by using the ATB Expression semi-automatic bacteria identification system of BioM6rieux, France, the bacterial identification was carried out according to the National clinical laboratory operation guidelines, the drug susceptibility testing was performed with the use of K-B method, the results were determined according to the CLSI criteria of 2010 edition, and all the data were statistically analyzed by using the WHONET5.6 software. RESULTS A total of 310 strains of pathogens have been isolated from the wounds of the burn patients, including 204 (65.8 %) strains of gram-positive bacteria and 106 (34.2%) strains of gram-negative bacteria; the Staphylococcus epidermidis, Staphylococcus hemolytic, Enterococcus faecalis, and Staphylococcus aureus were the predominant species of gram-positive bacteria, accounting for 19.7%, 13.2%, 8. 4%, and 8. 1%, respectively; the Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella pneumoniae were dominant among the gram-negative bacteria, accounting for 8.7%, 7.1%, 3.9%, and 3.5 %, respectively; the pandrug-resistant A. baumannii accounted for 81.5%, and the carbapenem-resistant P. aeruginosa accounted for 9.1%. The drug susceptibility rates of the gram-positive bacteria to vancomycin, linezolid, and teicoplanin were 100.0 % ; the drug susceptibility rates of the Enterobacteriaceae to carbapenems were 100.0%. CONCLUSION It is necessary to strengthen the surveillance of the pathogens isolated from the wounds of the burn patients so as to provide guidance for reasonable clinical use of antibiotics and strict implementation of disinfection and isolation measures.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第13期3185-3187,共3页 Chinese Journal of Nosocomiology
基金 江苏省卫生厅科研基金资助项目(H201014)
关键词 烧伤感染 病原菌 耐药性 Burn wound infection Pathogen Drug resistance
  • 相关文献

参考文献5

二级参考文献37

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 3侯天文,尹晓琳,马翠卿,徐树彬,陈晶,陈兴,李玮,白云.产DHA-1型AmpC酶和TEM-1型β-内酰胺酶及携带Ⅰ类整合子的鲍氏不动杆菌[J].中华医院感染学杂志,2006,16(8):853-857. 被引量:23
  • 4董晓勤,周田美,魏泽庆,俞云松,张红河,余道军,汪涛.杭州市区4所医院鲍氏不动杆菌耐药性及耐药基因研究[J].中华医院感染学杂志,2007,17(3):250-253. 被引量:17
  • 5Jeong SH, Bae I1 K, Park KO. Outbreaks of imipenem resistant Acinetobacter baumannii producing carbapenemases in Korea[J]. J Microbiol,2006,44(4) :423-431.
  • 6Bogaerts P, Naas T, Wybo I, et al. Outbreak of infection by carbapenem resistant Acinetobacter baumannil producing the carbapenemase OXA-58 in Belgium [J]. J Clin Microbiol, 2006,44(11) :4189-4192.
  • 7Villegas MV, Kattan JN, Correa A, et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals[J]. Antimicrob Agents Chemother, 2007,51(6) :2001-2004.
  • 8Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii :mechanisms and epidemiology[J]. Clin Microbiol Infect,2006,12(9) :826-836.
  • 9Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem resistant acinetobacter baumannii clones at multiple hospitals in London and Southeast England[J]. J Clin Microbiol, 2006,44(10) : 3623-3627.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Approved standard. M100-S15. CLSI,2005.

共引文献28

同被引文献5

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部